| Phaarmasia Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 523620 |
NSE Symbol : - |
P/E(TTM) : 70.09 |
|
ISIN Demat : INE486I01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.14 |
|
Book Value(₹) : 9.52 |
Market Cap(₹Cr) : 54.57 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 16.55 | 6.87 | 5.43 | 4.72 | 5.93 | 8.29 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 16.55 | 6.87 | 5.43 | 4.72 | 5.93 | 8.29 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.14 | 0.32 | 0.18 | 0.19 | 0.22 | 0.15 |
| Total Income | 16.69 | 7.19 | 5.61 | 4.91 | 6.15 | 8.44 |
| Total Expenditure | 14.94 | 6.78 | 6.05 | 5.52 | 6.71 | 8.11 |
| PBIDT | 1.75 | 0.40 | -0.43 | -0.60 | -0.56 | 0.33 |
| Interest | 0.00 | 0.03 | 0.00 | 0.01 | 0.00 | 0.00 |
| PBDT | 1.75 | 0.38 | -0.43 | -0.61 | -0.57 | 0.33 |
| Depreciation | 0.05 | 0.06 | 0.08 | 0.08 | 0.08 | 0.08 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.04 | 0.04 | 0.01 | 0.01 | 0.00 | -0.03 |
| Reported Profit After Tax | 1.74 | 0.27 | -0.53 | -0.70 | -0.64 | 0.28 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.74 | 0.27 | -0.53 | -0.70 | -0.64 | 0.28 |
| EPS (Unit Curr.) | 2.54 | 0.40 | -0.77 | -1.02 | -0.94 | 0.40 |
| EPS (Adj) (Unit Curr.) | 2.54 | 0.40 | -0.77 | -1.02 | -0.94 | 0.40 |
| Calculated EPS (Unit Curr.) | 2.54 | 0.40 | -0.77 | -1.02 | -0.94 | 0.40 |
| Calculated EPS (Adj) (Unit Curr.) | 2.54 | 0.40 | -0.77 | -1.02 | -0.94 | 0.40 |
| Calculated EPS (Ann.) (Unit Curr.) | 10.17 | 1.58 | -3.08 | -4.10 | -3.76 | 1.62 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 10.17 | 1.58 | -3.08 | -4.10 | -3.76 | 1.62 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 10.57 | 5.82 | -7.92 | -12.71 | -9.44 | 3.98 |
| PBDTM(%) | 10.57 | 5.53 | -7.92 | -12.92 | -9.61 | 3.98 |
| PATM(%) | 10.51 | 3.93 | -9.76 | -14.83 | -10.79 | 3.38 |